Edition:
United Kingdom

G1 Therapeutics Inc (GTHX.OQ)

GTHX.OQ on NASDAQ Stock Exchange Global Select Market

46.90USD
9:00pm BST
Change (% chg)

$0.09 (+0.19%)
Prev Close
$46.81
Open
$46.77
Day's High
$47.14
Day's Low
$45.76
Volume
129,059
Avg. Vol
132,716
52-wk High
$69.23
52-wk Low
$18.45

Latest Key Developments (Source: Significant Developments)

G1 Therapeutics qtrly ‍loss per share $0.55
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - G1 Therapeutics Inc ::G1 therapeutics reports third quarter 2017 financial results and recent operational highlights.G1 therapeutics inc - qtrly ‍loss per share $0.55.G1 therapeutics inc - qtrly loss per share ‍$0.55​.Q3 earnings per share view $-0.55 -- Thomson Reuters I/B/E/S.G1 therapeutics inc- ‍cash, cash equivalents and short-term investments totaled $118.4 million as of sept 30, 2017, versus $47.3 million as of dec 31, 2016​.  Full Article

G1 Therapeutics Inc appoints Barclay (Buck) Phillips as CFO and SVP, corporate development​
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - G1 Therapeutics Inc ::G1 Therapeutics Inc - appoints barclay (buck) phillips as chief financial officer and senior vice president, corporate development​.G1 Therapeutics Inc - ‍G1 announced that chief business officer Greg Mossinghoff will depart company in January of 2018​.  Full Article

BRIEF-G1 Therapeutics Reports Qtrly Loss Per Share Of $0.70

* G1 THERAPEUTICS PROVIDES FIRST QUARTER 2018 CORPORATE AND FINANCIAL UPDATE